Arachidonic acid-derived oxidation products initiate apoptosis in vascular smooth muscle cells

Piomelli, 1993, Arachidonic acid in cell signaling, Curr. Opin. Cell Biol., 5, 274, 10.1016/0955-0674(93)90116-8 Van Der Vusse, 1997, Accumulation of arachidonic acid in ischemic/reperfused cardiac tissue: possible causes and consequences, Prostaglandins Leukot. Essent. Fatty Acids, 57, 85, 10.1016/S0952-3278(97)90497-X Hennig, 1992, Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins, Atherosclerosis, 95, 235, 10.1016/0021-9150(92)90027-E Barry, 1997, Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles, J. Clin. Invest., 99, 2118, 10.1172/JCI119385 Barry, 1999, Arachidonic acid in platelet microparticles upregulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway, J. Biol. Chem., 274, 7545, 10.1074/jbc.274.11.7545 Kontos, 1983, Oxygen radicals and vascular damage, Adv. Exp. Med. Biol., 161, 365, 10.1007/978-1-4684-4472-8_20 Staub, 1994, Swelling, acidosis and irreversible damage of glial cells from exposure to arachidonic acid in vitro, J. Cereb. Blood Flow Metab., 14, 1030, 10.1038/jcbfm.1994.135 Thollon, 1995, Nature of the cardiomyocyte injury induced by lipid hydroperoxides, Cardiovasc. Res., 30, 648, 10.1016/S0008-6363(95)00075-5 Chen, 1997, Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P4502E1, J. Biol. Chem., 272, 14532, 10.1074/jbc.272.23.14532 Padma, 1999, Effect of cis-unsaturated fatty acids on the activity of protein kinases and protein phosphorylation in macrophage tumor (AK-5) cells in vitro, Prostaglandins Leukot. Essent. Fatty Acids, 60, 55, 10.1054/plef.1998.0008 Begin, 1985, Selective killing of human cancer cells by polyunsaturated fatty acids, Prostaglandins Leukot. Med., 19, 177, 10.1016/0262-1746(85)90084-8 Williams, 1998, Apoptosis in human primary brain tumors: actions of arachidonic acid, Prostaglandins Leukot. Essent. Fatty Acids, 58, 193, 10.1016/S0952-3278(98)90113-2 Wolf, 1999, Characterization of arachidonic acid-induced apoptosis, Cell. Biochem. Biophys., 30, 353, 10.1007/BF02738119 Das, 1999, Essential fatty acids, lipid peroxidation and apoptosis, Prostaglandins Leukot. Essent. Fatty Acids, 61, 157, 10.1054/plef.1999.0085 Herbst, 1999, 4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells, J. Cell. Physiol., 181, 295, 10.1002/(SICI)1097-4652(199911)181:2<295::AID-JCP11>3.0.CO;2-I Chen, 1997, Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P4502E1, J. Biol. Chem., 272, 14532, 10.1074/jbc.272.23.14532 Brash, 2001, Arachidonic acid as a bioactive molecule, J. Clin. Invest., 107, 1339, 10.1172/JCI13210 Cao, 2000, Intracellular unesterified arachidonic acid signals apoptosis, Proc. Natl. Acad. Sci. USA, 97, 11280, 10.1073/pnas.200367597 Scorrano, 2000, Arachidonic acid causes cell death through the mitochondrial permeability transition: implications for TNFalpha apoptotic signaling, J. Biol. Chem., 276, 12035, 10.1074/jbc.M010603200 Bauriedel, 1999, Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability, Cardiovasc. Res., 41, 480, 10.1016/S0008-6363(98)00318-6 Bennett, 1999, Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture, Cardiovasc. Res., 41, 361, 10.1016/S0008-6363(98)00212-0 Thompson, 1997, Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms, Coron. Artery Dis., 8, 623, 10.1097/00019501-199710000-00005 Bennett, 1997, Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis, Circ. Res., 81, 591, 10.1161/01.RES.81.4.591 Goodfriend, 1997, Non-esterified fatty acids in the pathogenesis of hypertension: theory and evidence, Prostaglandins Leukot. Essent. Fatty Acids, 57, 57, 10.1016/S0952-3278(97)90493-2 Reza Mehrabi, 1999, The isoprostane, 8-epi-PGF2 alpha, is accumulated in coronary arteries isolated from patients with coronary heart disease, Cardiovasc. Res., 43, 492, 10.1016/S0008-6363(99)00108-X Lucas, 1998, Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction, Proc. Natl. Acad. Sci. USA, 95, 510, 10.1073/pnas.95.2.510 Kimes, 1976, Characterization of two putative smooth muscle cell lines from rat thoracic aorta, Exp. Cell Res., 98, 349, 10.1016/0014-4827(76)90446-8 Rao, 1997, The A10 cell line: a model for neonatal, neointimal or differentiated vascular smooth muscle cells?, Cardiovasc. Res., 36, 118, 10.1016/S0008-6363(97)00156-9 Esterbauer, 1991, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic. Biol. Med., 11, 81, 10.1016/0891-5849(91)90192-6 Stocks, 1998, Capillary electrophoresis to monitor the oxidative modification of low density lipoproteins, J. Lipid Res., 39, 1305, 10.1016/S0022-2275(20)32556-6 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Yamada, 1998, Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study, Life Sci., 63, 289, 10.1016/S0024-3205(98)00448-2 Orlov, 1996, Apoptosis in vascular smooth muscle cells: role of cell shrinkage, Biochem. Biophys. Res. Commun., 221, 708, 10.1006/bbrc.1996.0661 Oberhammer, 1992, Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1, Proc. Natl. Acad. Sci. USA, 89, 5408, 10.1073/pnas.89.12.5408 Guijarro, 1998, 3-Hydroxy-3-methyl glutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture, Circ. Res., 83, 490, 10.1161/01.RES.83.5.490 Best, 1999, Apoptosis, basic concepts and implications in coronary artery disease, Arterioscler. Thromb. Vasc. Biol., 19, 14, 10.1161/01.ATV.19.1.14 Iglesias, 1999, Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS, Am. J. Physiol., 277, F711 Nishio, 1997, The involvement of reactive oxygen species and arachidonic acid in alpha-1 adrenoreceptor induced smooth muscle cell proliferation and migration, Br. J. Pharmacol., 121, 665, 10.1038/sj.bjp.0701171 Sagar, 1995, Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro, Prostaglandins Leukot. Essent. Fatty Acids, 53, 287, 10.1016/0952-3278(95)90129-9 Cocco, 1999, Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation, Free Radic. Biol. Med., 27, 51, 10.1016/S0891-5849(99)00034-9 Shin, 1999, Arachidonic acid induces the activation of the stress-activated protein kinase, membrane ruffling and H2O2 production via a small GTPase Rac1, FEBS Lett., 452, 355, 10.1016/S0014-5793(99)00657-2 Morisaki, 1982, Fatty acid specificity in the inhibition of cell proliferation and its relationship to lipid peroxidation and prostaglandin biosynthesis, Lipids, 17, 893, 10.1007/BF02534584 Weaver, 2001, Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells, Free Radic. Biol. Med., 30, 299, 10.1016/S0891-5849(00)00466-4 Gu, 2001, Evidence that increased 12-lipoxygenase activity induced apoptosis in fibroblasts, J. Cell Physiol., 186, 357, 10.1002/1097-4652(200103)186:3<357::AID-JCP1034>3.0.CO;2-E Gavino, 1981, Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures, J. Lipid Res., 22, 763, 10.1016/S0022-2275(20)37347-8 Terano, 1999, Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of cdk2–cyclinE complex, Biochem. Biophys. Res. Commun., 254, 502, 10.1006/bbrc.1998.9976 Vieira, 2001, The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal, Oncogene, 20, 4305, 10.1038/sj.onc.1204575 Ji, 2001, IKappa B kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal, J. Biol. Chem., 276, 18223, 10.1074/jbc.M101266200 Okada, 1999, 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules, J. Biol. Chem., 274, 23787, 10.1074/jbc.274.34.23787 Neely, 1999, The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin, J. Neurochem., 72, 2323, 10.1046/j.1471-4159.1999.0722323.x Steinberg, 1997, Low density lipoprotein oxidation and its pathobiological significance, J. Biol. Chem., 272, 20963, 10.1074/jbc.272.34.20963 McIntyre, 1999, Biologically active oxidized phospholipids, J. Biol. Chem., 274, 25189, 10.1074/jbc.274.36.25189 Perez-Sala, 1995, Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease, J. Biol. Chem., 270, 6235, 10.1074/jbc.270.11.6235 Yasunari, 1999, Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose, Circulation, 99, 1370, 10.1161/01.CIR.99.10.1370